ZA973836B - Pharmaceutical composition based on stabilized lipophilic matrices for the controlled release of active principles. - Google Patents

Pharmaceutical composition based on stabilized lipophilic matrices for the controlled release of active principles.

Info

Publication number
ZA973836B
ZA973836B ZA9703836A ZA973836A ZA973836B ZA 973836 B ZA973836 B ZA 973836B ZA 9703836 A ZA9703836 A ZA 9703836A ZA 973836 A ZA973836 A ZA 973836A ZA 973836 B ZA973836 B ZA 973836B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
controlled release
composition based
active principles
lipophilic matrices
Prior art date
Application number
ZA9703836A
Other languages
English (en)
Inventor
Gilles Fonknechten
Patrick Genty
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA973836B publication Critical patent/ZA973836B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9703836A 1996-05-06 1997-05-05 Pharmaceutical composition based on stabilized lipophilic matrices for the controlled release of active principles. ZA973836B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9605606A FR2748209B1 (fr) 1996-05-06 1996-05-06 Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs

Publications (1)

Publication Number Publication Date
ZA973836B true ZA973836B (en) 1997-12-02

Family

ID=9491845

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9703836A ZA973836B (en) 1996-05-06 1997-05-05 Pharmaceutical composition based on stabilized lipophilic matrices for the controlled release of active principles.

Country Status (16)

Country Link
EP (1) EP0806202B1 (xx)
JP (1) JP3983339B2 (xx)
CN (1) CN1171270A (xx)
AT (1) ATE212543T1 (xx)
AU (1) AU720146B2 (xx)
CA (1) CA2204475C (xx)
DE (1) DE69710121T2 (xx)
DK (1) DK0806202T3 (xx)
ES (1) ES2170922T3 (xx)
FR (1) FR2748209B1 (xx)
HU (1) HU222045B1 (xx)
NO (1) NO318227B1 (xx)
NZ (1) NZ314740A (xx)
PL (1) PL190562B1 (xx)
PT (1) PT806202E (xx)
ZA (1) ZA973836B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011363A3 (fr) * 1997-09-11 1999-08-03 Smb Technology Capsules semi-solides autoemulsionnables matricielles a action prolongee.
FR2782006B1 (fr) 1998-08-07 2002-04-19 Gattefosse Ets Sa Composition a liberation prolongee apte a former une micro-emulsion
DE10161078A1 (de) * 2001-12-12 2003-08-28 Achim Goepferich Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
WO2005016312A1 (en) 2003-08-13 2005-02-24 Nobex Corporation Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
GB0324574D0 (en) * 2003-10-21 2003-11-26 Glaxo Group Ltd Novel compositions
US8293270B2 (en) * 2005-10-26 2012-10-23 Banner Pharmacaps, Inc. Lipophilic vehicle-based dual controlled release matrix system
EP1959935A2 (en) 2005-10-26 2008-08-27 Banner Pharmacaps Inc. Hydrophilic vehicle-based dual controlled release matrix system as capsule fill
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
JP2013119540A (ja) * 2011-12-08 2013-06-17 Nipro Corp 固形医薬組成物およびその製造法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
DE4413350A1 (de) * 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate

Also Published As

Publication number Publication date
DK0806202T3 (da) 2002-05-06
DE69710121D1 (de) 2002-03-14
ATE212543T1 (de) 2002-02-15
PT806202E (pt) 2002-06-28
JP3983339B2 (ja) 2007-09-26
NO972068D0 (no) 1997-05-05
NO318227B1 (no) 2005-02-21
EP0806202A1 (fr) 1997-11-12
PL190562B1 (pl) 2005-12-30
CA2204475A1 (fr) 1997-11-06
NO972068L (no) 1997-11-07
AU1999197A (en) 1997-11-13
HU222045B1 (hu) 2003-04-28
FR2748209A1 (fr) 1997-11-07
AU720146B2 (en) 2000-05-25
FR2748209B1 (fr) 1998-06-05
CA2204475C (fr) 2002-12-03
CN1171270A (zh) 1998-01-28
PL319808A1 (en) 1997-11-10
HUP9700842A1 (hu) 1998-08-28
EP0806202B1 (fr) 2002-01-30
JPH1045629A (ja) 1998-02-17
ES2170922T3 (es) 2002-08-16
DE69710121T2 (de) 2002-11-28
NZ314740A (en) 1998-11-25
HU9700842D0 (en) 1997-06-30

Similar Documents

Publication Publication Date Title
EP0350246A3 (en) Sustained release microcapsule for water soluble drug
HK1010447A1 (en) Tramadol salt containing medicaments with sustained release of the active ingredient
ZA9811799B (en) Solid galenic form of the controlled release tablet type for the instant and then prolonged release of one or more active substances
EP1132104A3 (de) Spender für Medien
AU3418993A (en) System for delivering an active substance for sustained release
ZA937951B (en) Prodrugs,their preparation and use as pharmaceuticals
IL89748A (en) Pharmaceutical compositions for systemic transdermal administration, containing deprenyl
HU0301253D0 (en) Active ingredient containing plaster
CA2134885A1 (en) Reduced odor fragrance sampler
ZA894020B (en) Controlled release pharmaceutical formulation
AU651894B2 (en) Matrix tablet permitting the sustained release of indapamide after oral administration
ZA973836B (en) Pharmaceutical composition based on stabilized lipophilic matrices for the controlled release of active principles.
HU902253D0 (en) Insecticide preparatives containing phenyl-substituted heterocyclic compounds as active substance and process for producing the active substances
HUP0100024A3 (en) Pharmaceutical compositions for treating alzheimer's disease containing carvedilol as active ingredient
ZA961138B (en) Solid active ingredient compositions containing hydroxypropylcellulose.
ZA973495B (en) Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route.
CA2294448A1 (en) Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
HUT49808A (en) Process for producing retarde pharmaceutical compositions containing aselastine
ZA938848B (en) Stabilised superoxide dismutase (SOD) composition.
IL89521A0 (en) Controlled release system for orally administered active substances
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
ATE80797T1 (de) Hemizellulosematrix enthaltende arzneizubereitungen mit verzoegerter freisetzung.
GB9302004D0 (en) A device for protacted release of active substances,perfumes and similar volatile substances